| Amino acid-protecting groups A Isidro-Llobet, M Alvarez, F Albericio Chemical reviews 109 (6), 2455-2504, 2009 | 1083 | 2009 |
| Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules WRJD Galloway, A Isidro-Llobet, DR Spring Nature communications 1 (1), 1-13, 2010 | 859 | 2010 |
| Cleavable linkers in antibody–drug conjugates JD Bargh, A Isidro-Llobet, JS Parker, DR Spring Chemical Society Reviews 48 (16), 4361-4374, 2019 | 437 | 2019 |
| Spectroscopic Studies of the Chan–Lam Amination: A Mechanism-Inspired Solution to Boronic Ester Reactivity JC Vantourout, HN Miras, A Isidro-Llobet, S Sproules, AJB Watson Journal of the American Chemical Society 139 (13), 4769-4779, 2017 | 334 | 2017 |
| Sustainability challenges in peptide synthesis and purification: from R&D to production A Isidro-Llobet, MN Kenworthy, S Mukherjee, ME Kopach, K Wegner, ... The Journal of organic chemistry 84 (8), 4615-4628, 2019 | 308 | 2019 |
| Site-selective modification strategies in antibody–drug conjugates SJ Walsh, JD Bargh, FM Dannheim, AR Hanby, H Seki, AJ Counsell, X Ou, ... Chemical Society Reviews 50 (2), 1305-1353, 2021 | 251 | 2021 |
| Chan–Evans–Lam amination of boronic acid pinacol (BPin) esters: overcoming the aryl amine problem JC Vantourout, RP Law, A Isidro-Llobet, SJ Atkinson, AJB Watson The Journal of organic chemistry 81 (9), 3942-3950, 2016 | 139 | 2016 |
| Diversity-oriented synthesis of macrocyclic peptidomimetics A Isidro-Llobet, T Murillo, P Bello, A Cilibrizzi, JT Hodgkinson, ... Proceedings of the National Academy of Sciences 108 (17), 6793-6798, 2011 | 125 | 2011 |
| Sensitized Detection of Inhibitory Fragments and Iterative Development of Non‐Peptidic Protease Inhibitors by Dynamic Ligation Screening MF Schmidt, A Isidro‐Llobet, M Lisurek, A El‐Dahshan, J Tan, ... Angewandte Chemie International Edition 47 (17), 3275-3278, 2008 | 85 | 2008 |
| Sulfatase-cleavable linkers for antibody-drug conjugates JD Bargh, SJ Walsh, A Isidro-Llobet, S Omarjee, JS Carroll, DR Spring Chemical Science 11 (9), 2375-2380, 2020 | 65 | 2020 |
| Mechanistic Insight Enables Practical, Scalable, Room Temperature Chan–Lam N-Arylation of N-Aryl Sulfonamides JC Vantourout, L Li, E Bendito-Moll, S Chabbra, K Arrington, BE Bode, ... ACS Catalysis 8 (10), 9560-9566, 2018 | 65 | 2018 |
| Synthesis of unprecedented scaffold diversity WRJD Galloway, M Diáz‐Gavilán, A Isidro‐Llobet, DR Spring Angewandte Chemie International Edition 48 (7), 1194-1196, 2009 | 54 | 2009 |
| p‐Nitrobenzyloxycarbonyl (pNZ) as a Temporary Nα‐Protecting Group in Orthogonal Solid‐Phase Peptide Synthesis–Avoiding Diketopiperazine and Aspartimide Formation A Isidro‐Llobet, J Guasch‐Camell, M Álvarez, F Albericio European journal of organic chemistry 2005 (14), 3031-3039, 2005 | 48 | 2005 |
| MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo‐allergic and anaphylactoid reactions J Grimes, S Desai, NW Charter, J Lodge, R Moita Santos, A Isidro‐Llobet, ... Pharmacology Research & Perspectives 7 (6), e00547, 2019 | 44 | 2019 |
| One-pot homologation of boronic acids: A platform for diversity-oriented synthesis CW Muir, JC Vantourout, A Isidro-Llobet, SJF Macdonald, AJB Watson Organic Letters 17 (24), 6030-6033, 2015 | 43 | 2015 |
| A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds A Isidro-Llobet, KH Georgiou, WRJD Galloway, E Giacomini, MR Hansen, ... Organic & biomolecular chemistry 13 (15), 4570-4580, 2015 | 41 | 2015 |
| Fmoc‐2‐mercaptobenzothiazole, for the introduction of the Fmoc moiety free of side‐reactions A Isidro‐Llobet, X Just‐Baringo, A Ewenson, M Alvarez, F Albericio Peptide Science: Original Research on Biomolecules 88 (5), 733-737, 2007 | 41 | 2007 |
| Convergent approaches for the synthesis of the antitumoral peptide, kahalalide F. Study of orthogonal protecting groups C Gracia, A Isidro-Llobet, LJ Cruz, GA Acosta, M Álvarez, C Cuevas, ... The Journal of organic chemistry 71 (19), 7196-7204, 2006 | 36 | 2006 |
| Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences L Infante Lara, S Fenner, S Ratcliffe, A Isidro-Llobet, M Hann, B Bax, ... Nucleic acids research 46 (5), 2218-2233, 2018 | 34 | 2018 |
| EDOTn and MIM, new peptide backbone protecting groups A Isidro‐Llobet, X Just‐Baringo, M Alvarez, F Albericio Peptide Science 90 (3), 444-449, 2008 | 29 | 2008 |
